Erika Torjusen, M.D., M.H.S.

Director, Rare Pediatric Disease, Humanitarian Use Device, and Pediatric Device Consortia Programs
U.S. Food and Drug Administration

Abstracts(s):

• PC3017: Outcomes and Impact of the 2013-2018 FDA Pediatric Device Consortia Funding Cycle
  Monday, October 10, 2022

  1:30 PM – 2:30 PM US PDT